Aminoglycoside formulation for aerosolization

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5508269
SERIAL NO

08325705

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An aminoglycoside formulation for delivery by aerosolization. The concentrated aminoglycoside formulation containing an efficacious amount of aminoglycoside able to inhibit 95-100% of susceptible bacteria. Aminoglycoside formulated in 5 ml solution of a quarter normal saline having pH between 5.5 and 6.5. The method for treatment of endobronchial infections by a produced by a formulation delivered as an aerosol having mass medium average diameter predominantly between 1 to 5 .mu., produced by a jet or ultrasonic nebulizer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS VACCINES AND DIAGNOSTICS INC4560 HORTON STREET EMERYVILLE CALIFORNIA 94608 UNITED STATES OF AMERICA
NOVARTIS PHARMACEUTICALS CORPORATION59 ROUTE 10 EAST HANOVER NJ 07936

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Montgomery, Alan B Bellevue, WA 10 279
Ramsey, Bonnie W Seattle, WA 1 119
Smith, Arnold L Columbia, MO 6 280

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation